Human mast cell-derived gelatinase B (matrix metalloproteinase-9) is regulated by inflammatory cytokines: Role in cell migration

Journal of Immunology

Volumn 177, Issue 4, 2006, Pages 2638-2650

  Di Girolamo, Nick ^a   Indoh, Ikuko ^a   Jackson, Nicole ^a   Wakefield, Denis ^a   McNeil, H Patrick ^a   Yan, Weixing ^a   Geczy, Carolyn ^a   Arm, Jonathan P ^b   Tedla, Nicodemus ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GELATINASE B; GROWTH FACTOR; MATRIGEL; MESSENGER RNA; PROTEINASE; RECOMBINANT ENZYME; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL INVASION; CELL LINE; CELL MIGRATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; EFFECTOR CELL; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME REGULATION; ENZYME SYNTHESIS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; PROTEIN SYNTHESIS REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SECRETORY GRANULE; STEM CELL; SYNOVIUM; TISSUE INJURY; UMBILICAL CORD BLOOD; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY;

EID: 33746932123     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.4.2638     Document Type: Article

References (62)

1. Nakano, T., T. Sonoda, C. Hayashi, A. Yamatodani, Y. Kanayama, T. Yamamura, H. Asai, T. Yonezawa, Y. Kitamura, and S. J. Galli. 1985. Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal and intravenous transfer into genetically mast cell-deficient W/Wv mice: evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J. Exp. Med. 162: 1025-1043.
2. Metcalf, D. D., D. Baram, and Y. A. Mekori. 199. Mast cells. Physiol. Rev. 77: 1033-1079.
3. Williams, C. M., and S. J. Galli. 2000. The diverse potential effector and immunoregulatory roles of mast cells in allergic diseases. J. Allergy Clin. Immunol. 105: 847-859.
4. Galli, S. J., K. M. Zsebo, and E. N. Geissler. 1994. The kit ligand, stem cell factor. Adv. Immunol. 55: 1-16.
5. Madden, K. B., J. F. Urban Jr., H. J. Ziltener, J. W. Schrader, F. D. Finkelman, and I. M. Katona. 1991. Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis. J. Immunol. 147: 1387-1391.
6. Friend, D. S., N. Ghildyal, K. F. Austen, M. F. Gurish, R. Matsumoto, and R. L. Stevens. 1996. Mast cells that reside at different locations in the jejunum of mice infected with Trichinella spiralis exhibit sequential changes in their granule ultrastructure and chymase phenotype. J. Cell Biol. 135: 279-290.
7. Galli, S. J. 2000. Mast cells and basophils. Curr. Opin. Hematol. 7: 32-39.
8. Malone, D. G., R. L. Wilder, A. M. Saaverdra-Delgado, and D. D. Metcalfe. 1987. Mast cell numbers in rheumatoid synovial tissues: correlations with quantitative measures of lymphocytic infiltration and modulation by anti-inflammatory therapy. Arthritis Rheum. 30: 130-137.
9. Gotis-Graham, I., and H. P. McNeil. 1997. Mast cell responses in rheumatoid synovium: association of the MCTC subset with matrix turnover and clinical progression. Arthritis Rheum. 40: 479-489.
10. Abraham, S. N., and R. Malaviya. 1997. Mast cells in infection and immunity. Infect. Immun. 65: 3501-3508.
11. Echtenacher, B., D. N. Mannuel, and L. Hultner. 1996. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381: 75-77.
12. Lee, D. M., D. S. Friend, M. F. Gurish, C. Benolst, D. Mathis, and M. B. Brenner. 2002. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297: 1689-1692.
13. He, S., M. D. Gaca, and A. F. Walls. 2001. The activation of synovial mast cells: modulation of histamine release by tryptase and chymase and their inhibitors. Eur. J. Pharmacol. 412: 223-229.
14. Woolley, D. E., and L. C. Tetlow. 2000. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Arthritis Res. 2: 65-74.
15. Tetlow, L. C., and D. E. Woolley. 1995. Mast cells, cytokines and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies. Ann. Rheum. Dis. 54: 896-903.
16. Tetlow, L. C., N. Harper, T. Dunningham, M. A. Morris, H. Bertfield, and D. E. Woolley. 1998. Effects of induced masl cell activation on prostaglandin E and metalloproteinase production by rheumatoid synovial tissue in vitro. Ann. Rheum. Dis. 57: 25-32.
17. Sternlicht, M. D., and Z. Werb. 2001. How matrix metalloproteinases regulate cell behaviour. Annu. Rev. Cell Dev. Biol. 17: 463-516.
18. Yu, Q., and I. Stamenkovic. 2000. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev. 14: 163-176.
19. Baumann, P., P. Zigrino, C. Mauch, D. Breitkreutz, and R. Nischt. 2000. Membrane-type I matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes. Br. J. Cancer 83: 1387-1393.
20. Mengshol, J. A., S. M. Kimberlee, and C. E. Brinckerhoff. 2002. Matrix metalloproteinases as therapeutic targets in arthritic diseases. Arthritis Rheum. 46: 13-20.
21. Brew, K., D. Dinakarpandian, and H. Nagase. 2000. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim. Biophys. Acta 1477: 267-283.
22. Lohi, J., I. Harvima, and J. Keski-Oja. 1992. Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin. J. Cell. Biochem. 50: 337-349.
23. Fang, K. C., W. W, Raymond, S. C. Lazarus, and G. H. Caughey. 1996. Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase. J. Clin. Invest. 97: 1589-1596.
24. Ries, C., and P. E. Petrides. 1995. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol. Chem. Hoppe Seyler 376: 345-355.
25. Di Girolamo, N., P. McCluskey, A. Lloyd, M. T. Coroneo, and D. Wakefleld. 2000. Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Invest. Ophthalmol. Vis. Sci. 41: 671-679.
26. Vaday, G. G., H. Schor, M. A. Rabat, N. Lahat, and O. Lider. 2001. Transforming growth factor-β suppresses tumor necrosis factor α-induced matrix metalloproteinase-9 expression in monocytes. J. Leukocyte Biol. 69: 613-621.
27. Lacraz, S., P. Isler, E. Vey, H. G. Welgus, and J. M. Dayer. 1994. Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression. J. Biol. Chem. 269: 22027-22033.
28. Aoudjit, F., E. F. Potworowski, and Y. St-Pierre. 1998. Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T lymphoma/endothelial cell contact: implication of ICAM-1. J. Immunol. 160: 2967-2973.
29. Horwitz, A. R., and Z. Werb. 1998. Cell-to-cell contact and extracellular matrix cell adhesion and the extracellular matrix: recent progress and emerging themes. Curr. Opin. Cell Biol. 10: 562-565.
30. Sopata, I., and A. M. Dancewics. 1974. Presence of a gelatin-specific proteinase and its latent form in human leucocytes. Biochim. Biophys. Acta 370: 510-523.
31. Hibbs, M. S., K. A. Hasty, J. M. Seyer, A. H. Kang, and C. L. Mainardi. 1985. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J. Biol. Chem. 260: 2493-2500.
32. Okada, S., H. Kita, T. J. George, G. J. Gleich, and K. M. Leiferman. 1997. Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am. J. Respir Cell Mol. Biol. 17: 519-528.
33. Di Girolamo, N., and D. Wakefield. 2000. In vitro and in vivo expression of interstitial collagenase/MMP-1 by human mast cells. Dev. Immunol. 7: 131-142.
34. Brownell, E., L. Fiorentino, G. Jolly, K. Wolfe, S. Kincaid, P. Seperack, and D. Visco. 1995. Immunolocalization of stromelysin-related protein in murine mast cell granules. Int. Arch. Allergy Immunol. 107: 333-335.
35. Kanbe, N., A. Tanaka, M. Kanbe, A. Itakura, M. Kurosawa, and H. Matsuda. 1999.Human mast cells produce matrix metalloproteinase 9. Eur. J. Immunol. 29: 2645-2649.
36. Tanaka, A., K. Aria, Y. Kitamura, and H. Matsuda. 1999. Matrix metalloproteinase-9 production, a newly identified function of mast cell progenitors, is downregulated by c-kit receptor activation. Blood 94: 2390-2395.
37. Baram, D., G. G. Vaday, P. Salamon, I. Drucker, R. Hershkoviz, and Y. A. Mekori. 2001. Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-α. J. Immunol. 167: 4008-4016.
38. Tedla, N., K. Gibson, H. P. McNeil, D. Cosman, L. Borges, and J. P. Arm. 2002. The expression of activating and inhibitory leukocyte immunoglobulin-like receptors in rheumatoid synovium. Am. J. Pathol. 160: 425-431.
39. Ochi, H., W. M. Hirani, Q. Yuan, D. S. Friend, K. F. Austen, and J. A. Boyce. 1999. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J. Exp. Med. 190: 267-280.
40. 4 synthase expression by interleukin 4. J. Exp. Med. 193: 123-133.
41. Wang, H. W., N. Tedla, A. R. Lloyd, D. Wakefield, and H. P. McNeil. 1998. Mast cell activation and migration to lymph nodes during induction of an immune response in Mice. J. Clin. Invest. 102: 1617-1626.
42. Di Girolamo, N., A. Lloyd, P. J. McCluskey, M. Filipic, and D. Wakefield. 1997. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts. Am. J. Pathol. 105: 653-666.
43. Di Girolamo, N., M. T. Coroneo, and D. Wakefield. 2003. UVB-elicited induction of MMP-1 expression in human ocular surface epithelial cells is mediated through the ERK1/2 MAPK-dependent pathway. Invest. Ophthalmol. Vis. Sci. 44: 4705-4714.
44. Coussens, L. M., W. W. Raymond, G. Bergers, M. Laig-Webster, O. Behrendtsen, Z. Werb, G. H. Caughey, and D. Hanahan. 1999. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 13: 1382-1397.
45. DiMartino, M., C. Wolff, W. High, G. Stroup, S. Hoffman, J. Laydon, J. C. Lee, D. Bertolini, W. A. Gallowawy, M. J. Crimmin, et al. 1997. Anti-arthritic activity of hydroxamic acid-based pseudopeptide inhibitors of matrix metalloproteinases and TNFα processing. Inflamm. Res. 46: 211-215.
46. Ma, Z., H. Qin, and E. N. Benveniste. 2001. Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-γ and IFN-β: critical role of STATS-1α. J. Immunol. 167: 5150-5159.
47. Saren, P., H. G. Welgus, and P. T. Kovanen. 2001. TNF-α and IL-1β selectively induce expression of 92-kDa gelatinase by human macrophages. J. Immunol. 157: 4159-4165.
48. Keck, T., J. H. Balcom, 4th, C. Fernandez del Castello, B. A. Antoniu, and A. L. Warshaw. 2002. MMP-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis associated lung injury in the rat. Gastroenterology 122: 188-201.
49. Faveeuw, C., G. Preece, and A. Ager. 2001. Transendothelial migration of lymphocytes across high endothelial venules into lymph nodes is affected by metalloproteinases. Blood 98: 688-695.
50. Kandere-Grzybowska, K., R. Letourneau, D. Kempuraj, J. Donelan, S. Poplawski, W. Boucher, A. Athanassiou, and T. C. Theoharides. 2003. IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J. Immunol. 171: 4830-4836.
51. Coussens, L. M., C. L. Tinkle, D. Hanahan, and Z. Werb. 2000. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103: 481-490.
52. Fang, K. C., P. J. Wolters, M. Steinhoff, A. Bidgol, J. L. Blount, and G. H. Caughey. 1999. Mast cell expression of gelatinase A and B is regulated by kit ligand and TGF-β. J. Immunol. 162: 5528-5535.
53. Alvaro-Gracia, J. M., N. J. Zvaiffer, and G. S. Firestein. 1990. Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-γ and tumor necrosis factor-α on HLA-DR expression, proliferation, collagenases production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes. J. Clin. Invest. 86: 1790-1798.
54. Zhou, M., Y. Zhang, J. A. Ardans, and L. M. Wahl. 2003. Interferon-γ differentially regulates monocyte matrix metalloproteinase-1 and -9 through tumor necrosis factor-α and caspase 8. J. Biol. Chem. 278: 45406-45413.
55. Kumagai, K., I. Ohno, S. Okada, Y. Ohkawara, K. Suzuki, T. Shinya, H. Nagase, K. Iwata, and K. Shirato. 1999. Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma. J. Immunol. 162: 4212-4219.
56. Frank, B. T., J. C. Rossall, G. H. Caughey, and K. C. Fang. 2001. Mast cell tissue inhibitor of metalloproteinase-1 is cleaved and inactivated extracellularly by α-chymase. J. Immunol. 166: 2783-2792.
57. Opdenakker G., P. E. Van den Steen, and J. Van Damme. 2001. Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol. 22: 571-579.
58. Dubois, B., S. Masure, U. Hurtenbach, L. Paemen, H. Heremans, J. Van den Oord, R. Sciot, T. Meinhardt, G. Hämmerling, G. Opdenakker, and B. Arnold. 1999. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J. Clin. Invest. 104: 1507-1515.
59. Liu, Z., J. M. Shipley, T. H. Vu, X. Zhou, L. A. Diaz, Z. Werb, and R. M. Senior. 1998. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J. Exp. Med. 188: 475-482.
60. Wang, M., X. Qin, J. S. Mudgett, T. A. Ferguson, R. M. Senior, and H. G. Welgus. 1999. Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. Proc. Natl. Acad. Sci. USA 96: 6885-6889.
61. Heissig, B., K. Hattori, S. Dias, M. Friedrich, B. Ferris, N. R. Hackett, R. G. Crystal, P. Besmer, D. Lyden, M. A. Moore, et al. 2002. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109: 625-637.
62. 7) for tissue-specific homing. J. Exp. Med. 194: 1243-1252.